Interleukin-3 enhances the endogenous leukotriene production.
Denzlinger
C
C
Walther
J
J
Wilmanns
W
W
Gerhartz
H H
HH
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015251:Epirubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007377:Interleukin-3 / Q000627:therapeutic use* / Q000633:toxicity; D007958:Leukocyte Count; D007975:Leukotriene B4 / Q000652:urine; D015289:Leukotrienes / Q000096:biosynthesis*; D008223:Lymphoma / Q000097:blood / Q000188:drug therapy / Q000378:metabolism* / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use / Q000633:toxicity
D007377:Interleukin-3; D015289:Leukotrienes; D011994:Recombinant Proteins; D007975:Leukotriene B4; D015251:Epirubicin; D005047:Etoposide; D007069:Ifosfamide